As robotics and other systems improve, the physical aspect of pharmacy dispensing is bound to change how pharmacists do their job.
In October 2016 Mylan N.V. announced that its subsidiary, Mylan Inc., agreed to pay a $465 million settlement to the U.S. Department of Justice (DOJ) to resolve questions surrounding the classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector (EpiPen) for the Medicaid Drug Rebate Program.
The U.S. Department of Justice charged 16 individuals in Florida federal court as part of an elaborate fraud scheme that allegedly used call centers and kickbacks to generate bogus prescriptions and bilk government and private insurers for $175 million.
The Centers for Medicare and Medicaid Services (CMS) has once again released its Physician Fee Schedule Proposed Rule for Calendar Year 2017.
Many smaller organizations rely on the 340B program to continue serving their communities – and they can’t afford penalties for noncompliance.
The agreement between CVS and Massachusetts requiring the PMP check prior to dispensing opioids is believed to be the first in the nation.
According to FDA and other sources, tobacco use is the single largest preventable cause of disease and death in the United States.
FDA has stated that it intends to continue inspections of compounding pharmacies, and it has taken aggressive action, including enforcement actions, as appropriate to protect the public health.
Earlier this month, the U.S. Department of Justice announced that Rodney Dalton Logan, 63, of Muscle Shoals, Ala. agreed to plead guilty to obstructing a Medicare audit in 2012.
Will the DEA finally reclassify marijuana to schedule 2?